{"doi":"10.1016/j.febslet.2009.04.026","title":"Serum amyloid A and protein AA: Molecular mechanisms of a transmissible amyloidosis","abstract":"<jats:p>Systemic AA‐amyloidosis is a complication of chronic inflammatory diseases and the fibril protein AA derives from the acute phase reactant serum AA. AA‐amyloidosis can be induced in mice by an inflammatory challenge. The lag phase before amyloid develops can be dramatically shortened by administration of a small amount of amyloid fibrils. Systemic AA‐amyloidosis is transmissible in mice and may be so in humans. Since transmission can cross species barriers it is possible that AA‐amyloidosis can be induced by amyloid in food, e.g. foie gras. In mice, development of AA‐amyloidosis can also be accelerated by other components with amyloid‐like properties. A new possible risk factor may appear with synthetically made fibrils from short peptides, constructed for tissue repair.</jats:p>","journal":"FEBS Letters","year":2009,"id":37228,"datarank":3.6595762664086937,"base_score":4.584967478670572,"endowment":4.584967478670572,"self_citation_contribution":0.687745121800586,"citation_network_contribution":2.9718311446081076,"self_endowment_contribution":0.687745121800586,"citer_contribution":2.9718311446081076,"corpus_percentile":null,"corpus_rank":null,"citation_count":97,"citer_count":92,"citers_with_citation_signal":73,"citers_with_endowment":73,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":172898,"name":"Per Westermark","orcid":"0000-0002-2756-4995","position":1,"is_corresponding":false},{"id":187005,"name":"Gunilla T. Westermark","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":4.584967478670572,"endowment":4.584967478670572,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19393650","pmcid":null,"openalex_id":"https://openalex.org/W2150479300","authors":[],"funders":[],"total_grants":0,"fwci":3.4218,"citation_percentile":0.9308451,"influential_citations":3,"citation_trend":[{"year":2012,"count":11},{"year":2013,"count":7},{"year":2014,"count":2},{"year":2015,"count":5},{"year":2016,"count":10},{"year":2017,"count":2},{"year":2018,"count":4},{"year":2019,"count":7},{"year":2020,"count":4},{"year":2021,"count":6},{"year":2022,"count":5},{"year":2023,"count":7},{"year":2024,"count":5},{"year":2025,"count":4},{"year":2026,"count":4}],"oa_status":"bronze","license":"http://onlinelibrary.wiley.com/termsAndConditions#vor","oa_locations":[{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.febslet.2009.04.026","host_type":"journal"},{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.febslet.2009.04.026","host_type":"BRONZE"},{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.febslet.2009.04.026","host_type":"publisher"},{"url":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2Fj.febslet.2009.04.026","host_type":"publisher"},{"url":"https://febs.onlinelibrary.wiley.com/doi/pdf/10.1016/j.febslet.2009.04.026","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.febslet.2009.04.026","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/19393650","host_type":"repository"}],"fields_of_study":["Prion Diseases and Protein Misfolding","Amyloidosis: Diagnosis, Treatment, Outcomes","Trace Elements in Health","Chemistry","Medicine","Biology","Amyloid","Amyloidosis","Animals","Disease Transmission, Infectious","Humans","Inflammation","Mice","Prions","Serum Amyloid A Protein"],"mesh_terms":["Amyloid","Serum Amyloid A Protein","Amyloidosis","Animals","Humans","Inflammation","Prions","Disease Transmission, Infectious","Mice"],"keywords":["Amyloidosis","Amyloid fibril","AA amyloidosis","Amyloid (mycology)","Serum amyloid A","Fibril","Chemistry","Serum amyloid P component","Serum Amyloid A Protein","Medicine","Biochemistry","Pathology","Immunology","Disease","Inflammation","Amyloid β","C-reactive protein"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-10T18:50:09.103638Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}